Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. | EBioMedicine | 2022 | 35490460 | PubTator, text mining | PubMed |
| Bone Density, Geometry, and Mass by Peripheral Quantitative Computed Tomography and Bone Turnover Markers in Children with Diabetes Mellitus Type 1. | J Diabetes Res | 2022 | 35480630 | PubTator, text mining | PubMed |
| CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 Axis. | J Cardiovasc Transl Res | 2022 | 35467292 | PubTator, text mining | PubMed |
| Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing. | J Clin Med | 2022 | 35456240 | PubTator, text mining | PubMed |
| Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects. | Pharmaceuticals (Basel) | 2022 | 35455393 | PubTator, text mining | PubMed |
| Investigating the Effects of Conditioned Media from Stem Cells of Human Exfoliated Deciduous Teeth on Dental Pulp Stem Cells. | Biomedicines | 2022 | 35453661 | PubTator, text mining | PubMed |
| Inflammatory myofibroblastic tumor in the retromolar region of an 8-year-old child: A rare finding. | J Oral Maxillofac Pathol | 2022 | 35450238 | PubTator, text mining | PubMed |
| Editorial: Innovative Models in Bone Biology: What can be Learned From Rare Bone Diseases? | Front Endocrinol (Lausanne) | 2022 | 35432209 | PubTator, text mining | PubMed |
| The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases. | Inflammopharmacology | 2022 | 35419709 | PubTator, text mining | PubMed |
| Tanshinone Ameliorates Glucocorticoid-Induced Bone Loss via Activation of AKT1 Signaling Pathway. | Front Cell Dev Biol | 2022 | 35419360 | PubTator, text mining | PubMed |
| RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma. | Br J Cancer | 2022 | 35418213 | PubTator, text mining | PubMed |
| Relationship between rs7586085, GALNT3 and CCDC170 gene polymorphisms and the risk of osteoporosis among the Chinese Han population. | Sci Rep | 2022 | 35414641 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cells from Healthy and Inflamed Human Gingiva Respond Differently to Porphyromonas gingivalis. | Int J Mol Sci | 2022 | 35408871 | PubTator, text mining | PubMed |
| Senotherapeutics in Cancer and HIV. | Cells | 2022 | 35406785 | PubTator, text mining | PubMed |
| Periapical and endodontic status of patients with inflammatory bowel disease: Age- and sex-matched case-control study. | Int Endod J | 2022 | 35403728 | PubTator, text mining | PubMed |
| Biomedical features and therapeutic potential of rosmarinic acid. | Arch Pharm Res | 2022 | 35391712 | PubTator, text mining | PubMed |
| Concentrated Growth Factors Promote hBMSCs Osteogenic Differentiation in a Co-Culture System With HUVECs. | Front Bioeng Biotechnol | 2022 | 35387306 | PubTator, text mining | PubMed |
| The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital. | Neuropediatrics | 2022 | 35381604 | PubTator, text mining | PubMed |
| The Signaling Pathways Associated With Breast Cancer Bone Metastasis. | Front Oncol | 2022 | 35372035 | PubTator, text mining | PubMed |
| Reactive Oxygen Species in Cardiovascular Calcification: Role of Medicinal Plants. | Front Pharmacol | 2022 | 35370681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=48